Matt Devino, MPH
@matt_devino
Director, Advocacy and Strategic Alliances @PhRMA 💊Innovation advocate, 🦮Dog dad, 🏠CT native,📍NOVA transplant, 🎓Harvard & GW grad 🤓Opinions are my own
You might like
"The additional time provided by these treatments is clear. The value of this time is also clear when you listen directly to those who would benefit." @joannepikedrph shares our recommendation for traditional approval of Leqembi during today’s @US_FDA Advisory Committee meeting.
“I disagree with @CMSGov’s coverage decision to tightly restrict coverage for an entire class of FDA-approved Alzheimer’s drugs. There's a huge disconnect when FDA can approve a drug & CMS will not cover it.” Thank you @RepBarragan for being a leader for all that need #AccessNow.
In a new blog post, PhRMA’s Chief Medical Officer, @mybarra, recounts his experience working on the front line treating COVID-19 patients in the emergency department and the lessons learned on preserving an ecosystem that fosters innovation. catalyst.phrma.org/celebrating-th…
Patients deserve better than what they are currently getting from the 340B program. The new alliance, @ASAP340B, marks a historic, united step toward improving the program. We encourage policymakers and other stakeholders to join us. asap340b.org/post/new-allia…
asap340b.org
New Alliance of Health Care Leaders Calls on Congress to Save America’s 340B Program
Alliance to Save America’s 340B Program (ASAP 340B) Brings Together Unlikely Allies to Advance Real Solutions in Support of Protecting Patients and CommunitiesWashington, DC – More than 30 years ago,...
While biopharma companies work on treatments for sickle cell, hemophilia, depression & other diseases, lawmakers must work on policies that ensure patient out-of-pocket costs are based on the lower price middlemen pay. More in my @pharmaboardroom op-ed: bit.ly/3kL1cut
pharmaboardroom.com
The Inflation Reduction Act: What Needs Fixing & What’s Left to Address In Terms of Patient...
PhRMA President and CEO Stephen J. Ubl takes aim at the health insurers and pharmacy benefit…
During #RareDisease week, we just published this piece: How the Inflation Reduction Act is Impacting Rare Disease Patients (Including My Friends and Employees) @C4AHC cahc.net/newsroom/2023/…
cahc.net
How the Inflation Reduction Act is Impacting Rare Disease Patients
The IRA makes clear that companies developing orphan drugs are now at increased risk of market failure
My latest in @WSJ 👇🏻 "Using Qalys to make coverage or reimbursement decisions violates existing anti-discrimination laws designed to protect people with disabilities."
Disabled lives aren’t worth less, writes @MaryVought. Congress should ban the use of ‘quality-adjusted life years’ in healthcare coverage and insurance reimbursement decisions. on.wsj.com/3lfqOj2
For my first story @latimes, I went to Mexico and got drugs. Specifically, @ConnorASheets and I went to pharmacies, got pills & tested them. Turns out, some are selling oxy & Adderall over the counter – but the pills are actually fentanyl & meth. latimes.com/world-nation/s…
Good health policy piece from @SuePeschin The Powerful Private Organization Putting a Price on Life –Again and Again realclearhealth.com/articles/2023/…
ACCC added our voice to the overwhelming support for the Multi-Cancer Early Detection Screening Act. A majority of Congress & 400+ orgs support the bill. It’s time to pass it. @SenSchumer @LeaderMcConnell @SpeakerPelosi & @GOPLeader #passMCEDbillnow shiftcancer.org/action-portal/
Yikes…
Reposting for those who took a weekend Twitter break: Our piece on evidence of widespread fraud in the private Medicare Advantage program, poised to enroll the majority of Medicare beneficiaries next year. nytimes.com/2022/10/08/ups… @ReedAbelson
Today is the deadline for cancer programs and practices to apply for CMMI's new Enhancing Oncology Model (EOM). In case you missed it, I'm linking my blog post and commentary comparing EOM to its predecessor, the Oncology Care Model. Are you applying? accc-cancer.org/acccbuzz/blog-…
Governors across the political spectrum—in AZ, IL, LA, and RI—have supported similar legislation to expand access to #BiomarkerTesting. But @CAgovernor vetoed this bill, despite unanimous bipartisan support. #CallOnNewsom Read more: accc-cancer.org/acccbuzz/blog-…
#BiomarkerTesting is key to matching patients to targeted therapy that can improve their quality of life & survival. @CAgovernor's veto of #SB912 fails #cancer patients. We stand with @ACSCANCA to #CallOnNewsom. Sign the petition & make your voice heard: bit.ly/3CDG1ka
Do you know the 5 key pieces of #cancercare legislation that are currently top of mind for us? @matt_devino, MPH, is covering these now via the #FAN Town Hall. Join the conversation [bit.ly/3S1oGHm] & learn how you can advocate for change with just the click of a button.
![ACCCBuzz's tweet image. Do you know the 5 key pieces of #cancercare legislation that are currently top of mind for us? @matt_devino, MPH, is covering these now via the #FAN Town Hall. Join the conversation [bit.ly/3S1oGHm] & learn how you can advocate for change with just the click of a button.](https://pbs.twimg.com/media/FdM6OdWXEAAxxkx.jpg)
Today, @ASCO & ACCC released resources to help research sites increase equity, diversity & inclusion in cancer #clinicaltrials & address barriers to participation. - Just ASK™ Training Program & Guide - Site Self-Assessment Access both for free: bit.ly/2T7muV6 #ASCOACCC
Hot off the press! ACCC Director Cancer Care Delivery and Health Policy @matt_devino, MPH, lays out the four key differences between the #OCM and #EOM that interested applicants should consider: bit.ly/3ISieOS @OSSatACCC
And now the 2023 Hospital OPPS proposed rule is here. Happy weekend/summer reading! public-inspection.federalregister.gov/2022-15372.pdf
Talk about waiting until the last minute to renew the COVID-19 #PHE... Thanks @SecBecerra! aspr.hhs.gov/legal/PHE/Page…
For all the #healthpolicy wonks out there, @CMSGov published its 2023 Medicare Physician Fee Schedule this afternoon. Happy reading! cms.gov/newsroom/fact-…
United States Trends
- 1. Bills 125K posts
- 2. Josh Allen 11.2K posts
- 3. Dolphins 25.4K posts
- 4. Drake Maye 10.7K posts
- 5. Bears 46.9K posts
- 6. Giants 50.1K posts
- 7. Dart 19.1K posts
- 8. Bryce 13.1K posts
- 9. Ravens 29.3K posts
- 10. Caleb Williams 3,182 posts
- 11. Browns 27.3K posts
- 12. Vikings 24.6K posts
- 13. Saints 29.2K posts
- 14. Jonathan Taylor 22.4K posts
- 15. Henderson 9,494 posts
- 16. Justin Fields 2,694 posts
- 17. Ben Johnson 2,027 posts
- 18. Joe Brady 2,657 posts
- 19. JJ McCarthy 2,872 posts
- 20. Jefferson 7,692 posts
You might like
-
Anders Gilberg
@AndersGilberg -
Derek Griffin
@Derek_Griffin1 -
BCMHouston
@bcmhouston -
Halee Fischer-Wright
@DrHalee -
Claire Ernst
@ClaireErnstJD -
Texas Children's
@TexasChildrens -
Lyman Stone 石來民 🦬🦬🦬
@lymanstoneky -
Justin T. Haskins
@JustinTHaskins -
Colorectal Cancer Alliance
@CCAlliance -
American Red Cross Greater North Texas Region
@RedCrossNTX -
Donna Campbell
@DonnaCampbellTX -
NY State of Health
@NYStateofHealth -
AANP
@AANP_NEWS -
New York MGMA
@NewYorkMGMA -
Physicians for a National Health Program
@PNHP
Something went wrong.
Something went wrong.